However, DNMT3A mutations showed high prevalence in leukemia patients, with 20% in AML and 10% in myelodysplastic syndrome (MDS) [26,27], which led to further investigation of the role of DNMT3A in hematopoiesis. The gene discussed is DNMT3A; the disease is myelodysplastic syndrome.